Advertisement

South Indian Bank Revises One-Year MCLR to 9.75% Ahead of Lending Cycle Reset

Updated: June 18, 2025 17:28

Image Source: Business Upturn

Stay Ahead – Explore Now! Biocon Biologics Secures Health Canada Approval for Yesintek, Bolstering Global Biosimilar Expansion

Advertisement

STORIES YOU MAY LIKE

Image Source: ANI News

Ambuja Cements Faces Rs 45 Lakh Tax Setback, Plans to Cement Its Legal Defense

Image Source: Business Standard

Piramal Pharma Q2 FY26: ₹99 Crore Net Loss Amid CDMO Business Challenges, Revenue at ₹2,044 Crore

Image Source: Business Standard

Syngene Q2: Revenue Inches Up, Profit Slides Amid Biologics Headwinds

Advertisement

Image Source: Finowings

Mumbai’s Skyline Gets a New Jewel — Garuda’s ₹1,416 Crore Powai Heights Contract

Image Source: Reuters

Sun Pharma’s Strategic Pivot: U.S. Manufacturing Expansion on the Horizon

Image Source: CCL Products

CCL Products Powers Up Profits and Sustainability with Strategic Renewable Investment

Image Source: Business Standard

Britannia Bakes Up Strong Q2: Profit Surges 23%, Revenue Rises Steadily

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine